Skip to main content
. 2021 Dec 3;12:797165. doi: 10.3389/fpsyt.2021.797165

Table 1.

Demographics of participants at the time of the interview.

PANS* Psychiatric control Healthy control Comparison between groups
n = 24 n = 46 n = 35 Statistics
General parameters
Sex, m/f 11/13 22/24 23/12 C2(2) = 3.3; p = 0.20
Age, median (range) 12.5 (8–36) 17.5 (6–40) 14 (4–33) H(2) = 8.6; p = 0.014
Number of diagnoses, median (range)** 3.0 (1–11) 5.00 (1–13) 0 U = 621.5; p = 0.39
Beighton Score, median (range) 2.0 (0–9) 2.0 (0–7) 2.0 (0–7) H(2) = 0.31; p = 0.86
Beighton Score ≥ 5, n (%) 4 (17) 9 (20) 5 (14) C2(2) = 0.40; p = 0.82
Beighton Score ≥ 6, n (%) 3 (13) 5 (11) 3 (9) C2(2) = 0.25; p = 0.88
Psychiatric diagnoses, n (%)
Autism spectrum disorder 4 (17%) 18 (39%)
ADHD 11 (46%) 25 (54%)
Conduct disorder 0 2 (4%)
Oppositional disorder 5 (21%) 16 (35%)
Tourette's and tic disorder 13 (54%) 12 (26%)
Obsessive compulsive disorder 17 (71%) 21 (46%)
Generalised anxiety disorder 9 (38%) 21 (46%)
Social anxiety disorder 3 (13%) 15 (32%)
Panic disordera 6 (25%) 14 (30%)
Agoraphobia 3 (13%) 10 (22%)
Anorexia nervosa 1 (4%) 0
Bulimia nervosa 0 2 (4%)
Depressive disordersa 17 (71%) 26 (57%)
Bipolar and related disordersa 3 (13%) 3 (7%)
Trauma related disorders 1 (4%) 3 (7%)
Schizophrenia spectrum disordersa 9 (38%) 11 (24%)

PANS, paediatric acute-onset neuropsychiatric syndrome; ADHD, Attention-Deficit/Hyperactivity Disorder.

*

Lifetime paediatric acute-onset neuropsychiatric syndrome (PANS).

**

Comparisons are made between PANS and psychiatric controls.

a

Lifetime diagnosis.